The pattern visual evoked potential
dc.contributor.author | Brigell, Mitchell | en_US |
dc.contributor.author | Kaufman, David I. | en_US |
dc.contributor.author | Bobak, Phyllis | en_US |
dc.contributor.author | Beydoun, Ahmad A. | en_US |
dc.date.accessioned | 2006-09-08T20:32:32Z | |
dc.date.available | 2006-09-08T20:32:32Z | |
dc.date.issued | 1994-03 | en_US |
dc.identifier.citation | Brigell, Mitchell; Kaufman, David I.; Bobak, Phyllis; Beydoun, Ahmad; (1994). "The pattern visual evoked potential." Documenta Ophthalmologica 86(1): 65-79. <http://hdl.handle.net/2027.42/42623> | en_US |
dc.identifier.issn | 0012-4486 | en_US |
dc.identifier.issn | 1573-2622 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/42623 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=7956687&dopt=citation | en_US |
dc.description.abstract | The peak latency of the pattern-reversal visual evoked potential is a sensitive measure of conduction delay in the optic nerve caused by demyelination. Despite its clinical utility, the pattern-reversal visual evoked potential has not previously been used in multicenter clinical trials, presumably because of difficulty in standardizing conditions between centers. To establish whether the pattern-reversal visual evoked potential could be adequately standardized for use as a measure in multicenter therapeutic trials for optic neuropathy or multiple sclerosis, stimulus and recording variables were equated at four centers and pattern-reversal visual evoked potentials were recorded from 64 normal subjects and 15 patients with resolved optic neuritis. Results showed equivalent latency and amplitude data from all centers, suggesting that stimulus and recording variables can be satisfactorily standardized for multicenter clinical trials. N70 and P100 peak latencies and N70-P100 interocular amplitude difference were sensitive measures of resolved optic neuritis. | en_US |
dc.format.extent | 883595 bytes | |
dc.format.extent | 3115 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Kluwer Academic Publishers; Springer Science+Business Media | en_US |
dc.subject.other | Medicine & Public Health | en_US |
dc.subject.other | Ophthalmology | en_US |
dc.subject.other | Clinical Trials | en_US |
dc.subject.other | Demyelination | en_US |
dc.subject.other | Optic Neuropathy | en_US |
dc.subject.other | Visual Evoked Potential | en_US |
dc.title | The pattern visual evoked potential | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Opthalmology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Neurology, University of Michigan, Ann Arbor, USA | en_US |
dc.contributor.affiliationother | Department of Neurology, Loyola University Chicago, 2160 S. First Avenue, 60153, Maywood, IL, USA | en_US |
dc.contributor.affiliationother | Neuro-Ophthalmology Unit, Michigan State University, East Lansing, USA | en_US |
dc.contributor.affiliationother | Department of Ophthalmology, University of Illinois, Chicago, USA | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.identifier.pmid | 7956687 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/42623/1/10633_2005_Article_BF01224629.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1007/BF01224629 | en_US |
dc.identifier.source | Documenta Ophthalmologica | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.